Latest Security News

Metal Bank has secured $1.2 million through a placement at a 30% premium, enabling accelerated development at its Seven Leaders deposit and advancing gold projects at Livingstone.

Silver Mines has submitted a refreshed Biodiversity Development Assessment Report for its Bowdens Silver Project, moving the development application closer to redetermination by NSW authorities. The project remains a critical minerals priority with significant job creation potential.

Native Mineral Resources (ASX:NMR) has raised A$3.5 million through a convertible note with Lind Global Fund III LP, providing immediate working capital and flexibility for its growth plans.

Australis Oil and Gas has submitted a permit application for the first well under its US$46.25 million carried work program in the Tuscaloosa Marine Shale, targeting a Q4 2026 spud and expanding its held-by-production acreage.

Wide Open Agriculture is closing its German plant and pivoting to contract manufacturing in Asia to cut costs and scale lupin ingredient production efficiently under new CEO Craig Swan.

North Stawell Minerals (ASX:NSM) has expanded its gold footprint north of the Stawell Gold Mine, defining an 800-metre gold trend at Darlington and confirming significant mineralisation at Caledonia through re-split air core drilling assays.

Telix Pharmaceuticals has gained FDA alignment to advance Part 2 of its ProstACT Global Phase 3 trial for TLX591-Tx in metastatic castration-resistant prostate cancer, setting the stage for U.S. enrolment pending regulatory approval.

Lakes Blue Energy is positioning its Wombat Gas Project as a key contributor to Victoria's energy security and emerging AI infrastructure, with a conceptual study projecting a post-tax NPV10 of A$605 million and first gas in early 2029.

HALO Technologies launches a convertible notes offer aiming to raise up to A$6.75 million, backing platform upgrades and expansion across Asia-Pacific and adviser networks.

Algorae Pharmaceuticals has been appointed as a supplier under a NSW Health public hospital supply contract, marking a strategic milestone despite uncertain immediate revenue impact.

Firebird Metals secures independent international validation confirming its manganese sulphate surpasses 99.99% purity, well beyond Chinese industry benchmarks, reinforcing its proprietary processing edge and advancing its Australian Demonstration Plant.

Island Pharmaceuticals has strengthened its intellectual property portfolio with a Singapore patent covering ISLA-101 for flavivirus infections, including Dengue and Chikungunya, extending commercial exclusivity to 2034 in a key Asia-Pacific market.